Research Says Drug Delivery Devices Industry is Booming


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ research-says-drug-delivery-devices-industry-booming-treatment-covid19-patients
The increasing prevalence of chronic diseases is resulting in increased consumption of therapeutic drugs and therapies, and this factor is expected to act as a driver for the growth of the drug delivery devices market

The global drug delivery devices market is expected to grow from $1.4 billion in 2019 to about $1.6 billion in 2020, as there is a marginal increase in demand due to the use of such devices in the treatment of COVID-19 patients. The market is expected to stabilize and reach $1.9 billion at a CAGR of 8.2% through 2023. The drug delivery devices market in Asia-Pacific is forecasted to register the highest CAGR during 2019-2023.

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider drug delivery devices market, and compares it with other markets.

The increasing prevalence of chronic diseases is resulting in increased consumption of therapeutic drugs and therapies, and this factor is expected to act as a driver for the growth of the drug delivery devices market. The growth of the drug delivery devices market is limited by the regulatory changes related to medical devices.

The microneedle (MN), is a highly efficient and versatile medical device technology, due to its prominent properties including painless penetration, low cost, excellent therapeutic efficacy, and relative safety. The major players operating in the global microneedle drug delivery system include, 3M, Vetter Pharma International GmbH, nanoBioSciences LLC, NanoPass and more. The microneedles are fabricated using biodegradable polymers in which drugs or vaccines are encapsulated in the microneedles. Once, the microneedles dissolve in the skin, the drug gets released. This novel delivery method allows a wider variety of molecules to pass the skin's barrier, thus allowing the transdermal delivery to be applied to a large range of clinical applications, including diabetes, severe osteoporosis, and influenza vaccination.

Companies in the drug delivery devices market are collaborating with other companies within the industry in order to strengthen their product portfolio as well as to expand their footprint across different geographies. For instance, in July 2018, Gerresheimer AG, a Germany based provider of pharmaceutical packaging and drug delivery devices, acquired Sensile Medical AG for $413.4 million. The acquisition helped Gerresheimer AG in broadening its technological portfolio by enabling them to offer drug delivery devices for pharmaceutical and biopharmaceutical customers. Sensile Medical AG is a Switzerland based manufacturer of liquid drug delivery devices.

Major players in the drug delivery devices market are F. Hoffmann-La Roche, 3M Company, Pfizer, Baxter International, BD, Novartis, Gerresheimer, Johnson & Johnson Services, Bayer, and GlaxoSmithKline.

Tags : #DrugDeliveryDevice #JohnsonJohnson #GlaxoSmithKline #Novartis

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Single Surgeon Performs 17 Joint Replacements in 8 Hours at CARE Banjara, Setting New Benchmark in Orthopedic ExcellenceJuly 17, 2025
Sterling Hospitals Rajkot Achieves a Medical Milestone: Successfully Treats Rare and Life-Threatening Heart Condition RSOV Without Open Heart SurgeryJuly 17, 2025
Vidyadhan Alumni and Students Successfully Host Third Annual Blood Donation DriveJuly 17, 2025
HOSMAC Signs MoU with Gulf Medical University as Industry Partner to Strengthen Healthcare Education and CollaborationJuly 17, 2025
Why Teens Can’t Wake Up Early: The Hidden Problem of School TimingsJuly 17, 2025
Code Blue to Code Smart: How AI is Reshaping ICU Risk StratificationJuly 17, 2025
TERN Group Launches Its 7th Training Centre - and First Dedicated to Japanese Language & Careers - in GuwahatiJuly 16, 2025
Sri Sathya Sai Heart Hospital Ahmedabad and Rajkot signed an MOU with Gujarat Health Department for free heart surgery for needy children and adults July 16, 2025
No health without rights, says Shobha Shukla SDG-3 Lead Discussant at UN meetJuly 15, 2025
30 Minutes To Freedom, Robotic Surgery Ends 89-YO’s Swallowing NightmareJuly 15, 2025
Himalaya Wellness Champions Bhringaraja in New Anti-Hair Fall Campaign with a Tale of FriendshipJuly 15, 2025
ViiV Healthcare and Medicines Patent Pool extends voluntary licensing agreement to enable access to long-acting injectable HIV treatment July 15, 2025
Reforming global financial architecture is critical for gender equality and right to healthJuly 14, 2025
Francesco Arezzo takes office as president of Rotary InternationalJuly 14, 2025
CBM India Highlights Inclusive Eye Health at VISION 2020: The Right to Sight – INDIA 19th Annual ConferenceJuly 14, 2025
Crompton Introduces Ameo Fresh Nutri Blender, Reinforcing Its Promise of ‘Healthy Choices Made Easy’July 14, 2025
NMC Notifies Medical Institutions (Qualifications of Faculty) Regulations, 2025 to Expand Medical Education Capacity and Strengthen Faculty Availability July 14, 2025
India’s Roads, India’s Pain: Healing Beyond the HospitalJuly 14, 2025
When Weathers Go Deadly: Role Of Climate Change In Stimulating The Proliferation Of Disease-carrying VectorsJuly 14, 2025
India’s Hidden Health Emergency: Climate Pressures on WellbeingJuly 14, 2025